Amyloid light chain (AL) amyloidosis is a rare, debilitating, often fatal disease. Symptoms of
cardiomyopathy are common presenting features, and patients often are referred to …

Systemic AL (light chain) amyloidosis is a rare protein misfolding disorder associated with
plasma cell dyscrasia affecting various organs leading to organ dysfunction and failure. The …

Background We conducted a cross-sectional study to characterize health-related quality of
life and symptom burden in individuals living with light chain (AL) amyloidosis. Methods …

Background Light chain (AL) amyloidosis is a plasma cell neoplasm associated with high
early mortality and severe morbidity that can cause severe disability. We explored the impact …

背景免疫球蛋白轻链型心肌淀粉样变性(AL-CA) 进展快, 病死率高, 但目前对其临床特点认识
不足. 目的总结AL-CA 患者临床资料, 提高临床认知. 方法回顾性分析2012 年1 月—2016 年12 …

Background The immunoglobulin amyloid light-chain cardiac amyloidosis (AL-CA) has a
rapid progress and a high mortality rate, but its clinical characteristics are not fully …

Background Light chain (AL) amyloidosis is a plasma cell neoplasm associated with high
early mortality and severe morbidity that can cause severe disability. We explored the impact …

Cardiac amyloidosis is a type of amyloidosis in which one of the affected organs is the heart.
The disease is characterized by the formation of protein aggregates between the cells of the …